COMMUNIQUÉS West-GlobeNewswire

Oncology Venture provides financial details regarding its recent acquisition of additional ownership in dovitinib
13/06/2019
Press release Hoersholm, Denmark, June 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today informs that the previously announced acquisition of an additional 8% ownership in the dovitinib project [...]
Profound Medical Annual and Special Meeting of Shareholders Voting Results
13/06/2019
TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Progenics to Mail Letter to Shareholders
13/06/2019
Asks Shareholders to Vote “FOR” All the Company’s Qualified Directors on the WHITE Proxy Card NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“Progenics” or the “Company”), an [...]
VBI Vaccines Announces Results of Annual General Meeting
13/06/2019
CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI" or the "Company"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno- [...]
GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019
13/06/2019
GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019 Lille (France), Cambridge (Massachusetts, United States), June 13, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical [...]
GENFIT : Résultats de l’assemblée générale ordinaire du 13 juin 2019
13/06/2019
GENFIT : Résultats de l’assemblée générale ordinaire du 13 juin 2019 Lille (France), Cambridge (Massachusetts, États-Unis), le 13 juin 2019 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique de phase [...]
Zafgen to Present at the JMP Securities Life Sciences Conference
13/06/2019
BOSTON, June 13, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments
13/06/2019
Raised $70 Million in Gross Proceeds from Initial Public Offering and Concurrent Private Placement Initiated Phase 2 Clinical Trial for Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) NEW HAVEN, Conn [...]
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
13/06/2019
Unique patent-pending formulation of lamotrigine addresses significant unmet need in pediatric epilepsy patients NDA was submitted in May 2019; product launch anticipated in 1H 2020 Lamotrigine market currently exceeds [...]
Kezar Life Sciences Announces Promising Data from First in Patient Study of KZR-616 at EULAR 2019 Annual Meeting
13/06/2019
Repeat dosing of KZR-616 demonstrates tolerability and broad and consistent evidence of efficacy across multiple measures of disease activity Patients receiving KZR-616 have not experienced the hematologic and [...]
Constellation Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference
13/06/2019
CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
13/06/2019
Company announcement – No. 21 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, June 13, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR- [...]
YSS Corp. Announces Strategic Licensing Agreement and Acquisition of Call Right With Sweet Tree Modern Apothecary Ltd.
13/06/2019
CALGARY, Alberta, June 13, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PLQ7) is pleased to announce that effective as of today, YSS entered into a definitive agreement and closed [...]
Privacy Is Available—but at a Price, States Journal of American Physicians and Surgeons
13/06/2019
TUCSON, Ariz., June 13, 2019 (GLOBE NEWSWIRE) -- For patients who do not want all their medical data on the internet in these days of frequent cybercrime , Philip Eskew, D.O., J.D., M.B.A. offers some suggestions in the [...]
Prescription Drug Monitoring Programs Don’t Work, according to Article in the Journal of American Physicians and Surgeons
13/06/2019
TUCSON, Ariz., June 13, 2019 (GLOBE NEWSWIRE) -- In response to the rising rate of drug overdose deaths, 49 states had a Prescription Drug Monitoring Program (PDMP) by 2014. By requiring physicians to report all [...]
Dr. Whitney Hovenic of Skin Cancer & Dermatology Institute Announces the Acquisition of the Vbeam® Prima Laser System
13/06/2019
The new Vbeam Prima platform takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) to the next level RENO, Nev., June 13, 2019 (GLOBE NEWSWIRE) -- Dr. Whitney Hovenic of Skin Cancer & Dermatology Institute [...]
Inventiva announces the creation of its Scientific Advisory Board
13/06/2019
Inventiva announces the creation of its Scientific Advisory Board Daix (France), June 13, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the [...]
Inventiva annonce la création de son Conseil Scientifique
13/06/2019
Inventiva annonce la création de son Conseil Scientifique Daix (France), le 13 juin 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules [...]
Peter B. Schuna Appointed Co-Chair of Minnesota e-Health Advisory Committee
13/06/2019
LAKE ELMO, Minn., June 13, 2019 (GLOBE NEWSWIRE) -- Pathway Health , a leading post-acute consulting services, strategic technology implementation, and education services firm, is pleased to announce that Peter B. [...]

Pages